Fluid biomarker studies suggest that tau phosphorylated at threonine 217 (pT217) is one of the earliest accumulating pathological tau species in AD [8, 10, 24, 36, 38, 53] and can accurately predict amyloid pathology before the development of cognitive symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.